Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.67%) to 10402.44, DAX (0.01%) to 24852.69, CAC40 +0.33% to 8340.56, STOXX 600 (0.49%) to 618.52

Feb 12 ,2026

  • Synopsis:

    • European equity markets closed mostly lower, reversing earlier gains. EU Tech sector was notably under pressure, tracking weakness in US Big tech (AAPL, AMZN, META worst performers). Banks and Basic Resources also among EU sector underperformers. Gold slumped (2.5%) to ~$4969 while WTI Crude was (2.01%) to $63.33/bbl. Copper was down (2.55%).

    • In broader markets, hotter January US NFP and notable caveats, unrelenting AI disruption trade and dispersion continue to get outsized attention. Despite some debate over net implications from the notable headline surprise vs negative prior revisions, initial positive knee-jerk reactions were negated by the onset of dampened Fed rate cut expectations, taking market-implied odds of a June move below 50%. Yet Warsh nomination for Fed chair seemed to help sustain expectations of easing in H2. Miran later continued to advocate rate cuts for "a variety of reasons." Attention shifts to Friday's US CPI data.

    • UK data showed the economy ended 2025 on a weak footing. Q4 GDP expanded by 0.1% q/q, just short of the 0.2% consensus and follows Q3's 0.1% expansion. Left y/y growth of 1.0% versus consensus 1.2% and prior 1.2% revised from 1.3%. Growth was driven by a 1.2% increase in production, but construction fell 2.1% and the services sector saw no growth. The ONS monthly GDP estimate saw an expansion of 0.1% in December, in line with expectations and compared with prior 0.3% increase. Service sector grew 0.3% in December, but production dropped 0.9% and construction was 0.5% lower. Fits in with BoE analysis pointing to subdued underlying growth and weak growth in potential supply. Note, however, that PMI data has been consistently positive. January update hit a five-month high, pointing to improving growth rate at the start of the year, retail sales has improved, and housing market activity is picking up. Some thoughts that activity may gain traction into the spring, with inflation set to ease further and BoE expected to cut rates.

    • RICS January UK housing market survey points to signs of recovery. Price indicator recorded a net balance of -10% versus consensus -11% and prior -14%, continuing steady improvement from October 2025 low of -19%. Was the least negative since June when it recorded -7% but has not been positive since March 2025. While negative print still suggests weak momentum, fits in with recent updates from Nationwide and Halifax, which saw price recovery in January after a poor Q4 2025. Price growth the strongest in Scotland, Northern Ireland and Northwest and North of England, while London and south of the country lag. Overall activity still somewhat subdued, though new buyer enquiries reading at -15% versus prior -21% and November's -29% outturn. Similar trend in agreed sales, with a net balance of -9%, which was the least negative since June 2025. Medium-term expectations very upbeat, with sales expectations at +4% in the next three months and +35% over 12 months, the strongest since December 2024. Price expectations the highest since February 2025 on a yearly basis at +43%.

    • In M&A, Nuveen (asset management arm of TIAAA, Teachers Insurance and Annuity Association of America) is to acquire Schroders (SDR.LN) in a £9.9B recommended cash offer with shareholders to receive up to 612p per share (cash590 pence per Schroders, Dividends 22 pence).

    • Busy day for earnings/updates in the region. In Germany, Siemens (SIE.GR) Q1 beat and upgraded EPS outlook; Deutsche Boerse (DB1.GR) also reported solid, broadly in-line results. ThyssenKrupp (TKA.GR) reported mixed Q4 results and confirmed guidance; shares fell ~(12%). Mercedes-Benz Group (MBG.GR) also ended lower amid Q4 miss and disappointing FY26 Cars EBIT margin guidance. In France, Legrand (LR.FP) reported better than expected Q4 earnings and revenues, with 2026 guidance seen as a strong relief. Hermes (RMS.FP) also posted FY numbers ahead of consensus. EssilorLuxottica (EL.FP) reported Q4 revenue that exceeded estimates, fuelled by strong performance in the Professional Solutions division and continued momentum in smartglasses sales. However, analysts point out that the EBIT in the second half of the year was hit by pricing and FX headwinds, resulting in FY margins that fell short of consensus and declined y/y. Analysts also flag that management issued new long-term guidance, reassuring investors about recent margin pressures. Anheuser-Busch InBev (ABI.BB) posted Q4 beat as volume decline slows Sanofi (SAN.FP) CEO Paul Hudson to step down on 17-Feb; appoints Belén Garijo as new CEO. Adyen (ADYEN.NA) saw a negative reaction to FY results and guidance.

    • Elsewhere, European cement manufacturers such as HEI.GR, HOLN.SW, BZU.IM were under pressure after Germany called for revision or delay to the EU's emissions trading system, sending carbon prices tumbling from ~€75/tonne (Reuters).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Telecom +1.91%, Food & Beverage +1.81%, Health Care +0.49%, Real Estate +0.45%, Autos & Parts +0.39%, Persnl & HHold Goods +0.32%, Travel & Leisure +0.31%, Financial Svcs +0.12%, Insurance +0.04%, Chemicals (0.30%)

      • Underperformers:

        • Technology (1.91%), Banks (1.89%), Basic Resources (1.87%), Construct & Mtls (1.78%), Oil & Gas (1.24%), Ind Goods & Svcs (1.13%), Media (0.86%), Utilities (0.74%), Retail (0.58%)

    • Macro:

      • Central banks

        • BOE's Breeden Expects Rate Cut Within Next Two Months (Bloomberg)

        • ECB to broaden access to euro backstop, board member says (Reuters)

      • France

        • French first quarter GDP growth seen at 0.2%-0.3%, central bank chief says (Reuters)

      • Germany

        • For first time since stepping down as Chancellor, Angela Merkel will attend the CDU party conference (Handelsblatt)

        • Number of jobs in Germany dependent on exports to China has fallen sharply since 2021 (IW)

    • Company news:

      • Notable Gainers

        • +50.1% MVIR.SS (Medivir SEK1.06, +0.48) -- partner Vetbiolix initiates study

        • +28.6% SDR.LN (Schroders £5.89, +1.31) -- Pantheon to acquire Schroders in £9.9B recommended cash offer; earnings

        • +25.3% INSTAL.SS (Instalco SEK30.08, +6.42) -- earnings

        • +23.1% CYAD.BB (Celyad Oncology €0.28, +0.05) -- sale of C-CATHez Catheter to CellProthera

        • +18.7% EMBRAC.B.SS (Embracer Group SEK51.80, +8.57) -- earnings

        • +17.8% AUTO.NO (AutoStore Holdings NOK12.69, +1.97) -- earnings

        • +14.0% TIETO.FH (Tietoevry €18.24, +2.34) -- earnings; buyback; considers delisting from Nasdaq Stockholm

        • +11.7% SEDANA.SS (Sedana Medical SEK10.44, +1.12) -- earnings

        • +11.1% VIMIAN.SS (Vimian Group SEK28.00, +2.80) -- earnings

        • +8.6% FAGR.BB (Fagron €22.65, +1.85) -- earnings

        • +7.4% SECARE.SS (Swedencare SEK24.15, +1.70) -- earnings

        • +6.8% INTEA.B.SS (Intea Fastigheter AB SEK69.85, +4.60) -- Handelsbanken upgrade

        • +6.3% IPN.FP (Ipsen €148.80, +8.80) -- earnings

        • +6.2% NKR.NO (Nekkar NOK13.00, +0.75) -- earnings

        • +5.8% DOC.AV (DO & CO €191.80, +11.00) -- earnings

        • +5.7% ABI.BB (Anheuser-Busch InBev €65.84, +3.68) -- earnings

        • +5.6% NIBE.B.SS (NIBE Industrier SEK40.15, +2.06) -- earnings

        • +5.6% AZT.NO (ArcticZymes Technologies NOK25.00, +1.20) -- earnings

        • +5.3% VSSAB.B.SS (Viking Supply Ships SEK139.50, +7.00) -- earnings

        • +5.3% TGS.NO (TGS-NOPEC Geophysical Co. NOK110.40, +5.60) -- earnings

        • +5.1% MGNS.LN (Morgan Sindall Group £53.80, +2.60) -- trading update

        • +5.0% SIP.BB (Sipef €88.20, +4.20) -- earnings

        • +4.9% SDZ.SW (Sandoz Group CHF65.80, +3.08) -- Jefferies upgrade

        • +4.9% ML.FP (Cie Generale des Etablissements Michelin SA €34.50, +1.58) -- earnings

        • +4.2% EL.FP (EssilorLuxottica €270.60, +10.50) -- earnings

        • +4.2% VEI.NO (Veidekke NOK191.60, +7.60) -- earnings

        • +3.8% FLOW.NA (Flow Traders €26.42, +0.98) -- earnings

        • +3.5% GRE.SM (Grenergy Renovables €104.20, +3.40) -- financing

        • +3.5% BCVN.SW (Banque Cantonale Vaudoise CHF107.60, +3.80) -- earnings

        • +3.5% NONG.NO (SpareBank 1 Nord-Norge NOK150.74, +5.14) -- earnings

        • +3.5% DVYSR.SS (Devyser Diagnostics SEK99.00, +3.60) -- acquisition; earnings

        • +3.4% EUROB.GA (Eurobank SA €4.12, +0.14) -- Goldman Sachs upgrade

        • +3.1% FUR.NA (Fugro €12.00, +0.35) -- Kepler Cheuvreux upgrade

        • +3.0% LR.FP (Legrand €151.35, +4.35) -- earnings

        • +2.8% MING.NO (SpareBank 1 SMN NOK205.70, +5.59) -- earnings

        • +2.3% NN.NA (NN Group €71.32, +1.56) -- earnings

        • +2.1% VERK.FH (Verkkokauppa.com €4.00, +0.08) -- earnings

        • +1.6% REG1V.FH (Revenio Group €18.84, +0.28) -- SEB upgrade

        • +1.5% BIOVIC.B.SS (Biovica International SEK0.41, +0.01) -- data publication

        • +1.1% HEX.NO (Hexagon Composites NOK8.89, +0.09) -- earnings

        • +1.0% LRS1.GR (HomeToGo €1.48, +0.02) -- prelim earnings

        • +0.3% SIE.GR (Siemens AG €271.25, +0.75) -- earnings; CFO appointment

      • Notable Decliners

        • -24.0% CAMX.SS (Camurus SEK526.50, -161.00) -- earnings

        • -21.9% ADYEN.NA (Adyen €953.60, -252.90) -- earnings

        • -21.6% LIME.SS (Lime Technologies SEK209.00, -49.00) -- earnings

        • -17.5% YUBICO.SS (Yubico SEK56.16, -11.18) -- earnings

        • -16.4% VSURE.SS (Verisure Plc SEK11.79, -2.05) -- earnings

        • -15.4% CLA.FP (Claranova €0.81, -0.14) -- prelim sales

        • -14.5% LEON.SW (Leonteq CHF12.96, -2.12) -- earnings

        • -14.2% MEKKO.FH (Marimekko €11.74, -1.84) -- earnings

        • -13.8% NIL.B.SS (Nilörngruppen SEK51.30, -8.70) -- earnings

        • -13.0% VOLO.SS (Volati SEK89.00, -12.00) -- earnings

        • -11.9% AMBEA.SS (Ambea AB SEK116.40, -15.70) -- earnings

        • -11.7% PREC.SS (Precise Biometrics SEK1.83, -0.25) -- earnings

        • -10.6% HARVIA.FH (Harvia €35.60, -4.20) -- earnings

        • -10.2% CRAD.B.SS (C-RAD SEK26.25, -3.20) -- earnings

        • -10.2% TRAD.SS (Tradedoubler SEK6.14, -0.78) -- earnings

        • -10.2% MEKO.SS (MEKO AB SEK69.10, -7.30) -- earnings

        • -9.8% ELMRA.NO (Elmera Group NOK36.20, -4.00) -- earnings

        • -9.3% LINK.NO (LINK Mobility Group Holding NOK24.00, -2.35) -- earnings

        • -9.2% GENO.SS (Genovis SEK19.50, -1.82) -- earnings

        • -8.5% DSFIR.NA (DSM-Firmenich €62.46, -5.84) -- earnings

        • -8.0% ALICA.FP (ICAPE Holding €5.94, -0.52) -- sales; TPICAP Midcap downgrade

        • -8.0% GNC.LN (Greencore Group £2.79, -0.24) -- licensing partnership with Greencore (GLEN.LN)

        • -7.3% HFG.GR (HelloFresh €5.09, -0.40) -- prelim earnings

        • -7.2% ACR.NO (Axactor NOK8.08, -0.62) -- earnings

        • -7.0% RECSI.NO (REC Silicon NOK0.46, -0.03) -- earnings

        • -6.9% RTO.LN (Rentokil Initial £4.54, -0.33) -- Rollins (ROL) earnings sympathy

        • -6.7% BIOG.B.SS (BioGaia SEK106.00, -7.10) -- earnings

        • -6.5% CAPMAN.FH (Capman €1.85, -0.12) -- earnings

        • -6.4% LIAB.SS (Lindab International SEK188.20, -12.30) -- earnings

        • -5.7% SYNSAM.SS (Synsam SEK59.70, -3.60) -- new brand launch

        • -5.6% AQ.SS (AQ Group SEK184.60, -11.00) -- earnings

        • -5.0% KOMPL.NO (Komplett NOK13.25, -0.70) -- earnings

        • -4.8% LSS.FP (Lectra €21.75, -1.05) -- earnings

        • -4.5% TEKNA.NO (Tekna Holding NOK3.81, -0.19) -- earnings

        • -4.2% METSO.FH (Metso Corp. €16.67, -0.72) -- earnings

        • -4.2% SAN.FP (Sanofi €81.02, -3.46) -- CEO steps down

        • -4.1% ATORX.SS (Alligator Bioscience SEK0.19, -0.01) -- earnings

        • -4.0% RAY.B.SS (RaySearch Laboratories SEK184.80, -7.00) -- earnings

        • -3.4% PEXIP.NO (Pexip Holding NOK69.80, -2.40) -- earnings

        • -3.3% ONTEX.BB (Ontex Group €4.80, -0.17) -- earnings

        • -2.9% KEMIRA.FH (Kemira €20.68, -0.62) -- earnings; buyback

        • -2.9% NORCO.NO (Norconsult NOK41.75, -1.25) -- earnings

        • -2.7% AMS.SM (Amadeus IT Group €49.20, -1.36) -- Citi downgrade

        • -2.4% SOFF.NO (Solstad Offshore NOK48.85, -1.20) -- earnings

        • -2.3% AERO.SW (Montana Aerospace CHF34.00, -0.75) -- earnings

        • -2.1% WSTEP.NO (Webstep $18.40, -0.40) -- earnings

        • -1.9% LIN.FP (Linedata Services €40.30, -0.80) -- earnings

        • -1.4% HIAB.FH (Hiab €47.70, -0.71) -- earnings

        • -1.4% MBG.GR (Mercedes-Benz Group €55.32, -0.84) -- earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Aedifica (AED.BB), Heijmans (HEIJM.NA), CM.com (CMCOM.NA)

        • DACHs: Mobimo Holding (MOBN.SW), Fabasoft (FAA.GR)

        • Finland: Huhtamaki (HUH1V.FH), Kalmar (KALMAR.FH), Terveystalo (TTALO.FH), Enento Group (ENENTO.FH), Viking Line (VIK1V.FH), Relais Group (RELAIS.FH), Koskisen (KOSKI.FH), HKFoods (HKFOODS.FH), Apetit (APETIT.FH), Teleste (TLT1V.FH), Loihde (LOIHDE.FH), Glaston (GLA1V.FH)

        • France: Safran (SAF.FP), Capgemini (CAP.FP), Eutelsat Communications (ETL.FP)

        • Norway: Norsk Hydro (NHY.NO), Aker (AKER.NO), Tomra Systems (TOM.NO), Sparebank 1 Ostlandet (SPOL.NO), AF Gruppen (AFG.NO), Norwegian Air Shuttle (NAS.NO), Arendals Fossekompani (AFK.NO), Bouvet (BOUV.NO), Klaveness Combination Carriers (KCC.NO), SmartCraft (SMCRT.NO), AKVA Group (AKVA.NO), Hofseth BioCare (HBC.NO)

        • Southern Europe: Interpump Group (IP.IM)

        • Sweden: NCAB Group (NCAB.SS), Alligo (ALLIGO.B.SS), Humble Group (HUMBLE.SS), Haypp Group (HAYPP.SS), Karnell Group (KARNEL.B.SS), KlaraBo (KLARA.B.SS), Arise (ARISE.SS), Bjorn Borg (BORG.SS), Viking Supply Ships (VSSAB.B.SS), Eltel (ELTEL.SS), FormPipe Software (FPIP.SS), CDON (CDON.SS), Novotek (NTEK.B.SS), Oneflow (ONEF.SS), 4C Group (4C.SS), Corem Property Group (CORE.A.SS), Logistea (LOGI.A.SS), Karolinska Development (KDEV.SS), Lammhults Design Group (LAMM.B.SS)

        • UK: NatWest Group (NWG.LN)

      • Trading Update:

        • France: Delta Plus Group (ALDLT.FP)

  • Data:

    • Economics:

      • Jan CPI

        • Netherlands +2.4% y/y vs preliminary +2.4%

        • Greece +2.5% y/y vs consensus +2.7% and prior +2.6%

      • UK

        • Q4 Preliminary GDP +1.0% y/y vs consensus +1.2% and prior revised +1.2% from +1.3%

        • house price balance (10%) vs consensus (11%) and prior revised (13%) from (14%) - RICS

        • Dec

          • Construction Output (0.3%) y/y vs consensus 0.0% and prior revised (0.3%) from (1.1%)

          • Industrial Production +0.5% y/y vs consensus +1.5% and prior +2.3%

          • Visible Trade Balance (£22.72B) vs consensus (£22.3B) and prior revised (£23.58B) from (£23.71B)

    • Markets:

      • WTI Crude (Mar 26): ($1.36) or (2.10%) to $63.27

      • €-$ +0.0003 or +0.03% to 1.1876

      • £-$ +0.0001 or +0.01% to 1.3630

      • S&P (1.02%)

      • Performance year-to-date

        • FTSE 100: +4.74%

        • DAX: +1.48%

        • CAC: +2.34%

        • MIB: +2.84%

        • Stoxx 600: +4.45%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE